Handelsbanken Fonder
AIMT

Handelsbanken Fonder’s Aimmune Therapeutics AIMT Stock Holding History

Handelsbanken Fonder’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8,100
Closed -$279K – 1568
2020
Q3 		$279K Buy
+8,100
New +$173K ﹤0.01% 1279

Handelsbanken Fonder's AIMT Position: Q4 2020 in Review

Handelsbanken Fonder sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 8,100 shares — an estimated $279K sold.

Handelsbanken Fonder first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $279K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Handelsbanken Fonder reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Handelsbanken Fonder sold 8,100 Aimmune Therapeutics shares in Q4 2020, an estimated $279K.
  • Handelsbanken Fonder first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
  • Handelsbanken Fonder's Aimmune Therapeutics position peaked at $279K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Handelsbanken Fonder's 13F filing for Q4 2020, filed 11 Feb 2021.